NDAINJECTIONINJECTABLE
Approved
Jul 1956
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYDELTRA-TBA (prednisolone tebutate) is a corticosteroid injection approved in 1956 for anti-inflammatory and immunosuppressant therapy. It is administered via injection and used across multiple indications requiring systemic corticosteroid effect. The drug works through glucocorticoid receptor activation to suppress inflammation and immune responses.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30%), signaling potential team contraction and transition to generic defense or brand maintenance mode.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HYDELTRA-TBA at LOE approach means limited career growth potential within the product team; roles focus on defensive commercialization, generic transition planning, and market maintenance. Career advancement typically requires rotation to growth-stage products or lateral moves into specialty areas like pricing, payer relations, or legacy product optimization.
Brand Manager
Worked on HYDELTRA-TBA at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.